Uncategorized

Occlutech Holding AG is a leading specialist provider of minimally invasive structural heart implants.

IRLAB Therapeutics AB announced that the company will hold a presentation in conjunction with the publication of the interim report for the period January-March 2023.

Innate Pharma SA, announced that the Company will hold a conference call on Wednesday, May 10, 2023 at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first quarter of 2023.

Lannett Company, Inc. announced that it and certain of its subsidiaries have commenced prepackaged Chapter 11 cases in the United States Bankruptcy Court for the District of Delaware to effectuate the transactions contemplated by the Restructuring Support Agreement announced on May 1, 2023.

Skyline Therapeutics announced multiple data presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting in Los Angeles, CA, May 16-20, 2023.

Hyundai Bioscience announced on the 28th that it had received the clinical study report for the COVID-19 phase 2 clinical trial of its antiviral drug ‘Xafty’.

Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation and ventricular tachycardia, announced the completion of enrollment in its Cryocure-VT trial of ultra-low temperature cryoablation for the treatment of monomorphic ventricular tachycardias.

In addition to promoting their brands, companies say their funding initiatives give them access to the expertise of top researchers and contribute to society.

CHS continued to grapple with heightened expenses in the quarter, including a sequential increase in salary and benefit expenses and supply costs, executives said on a Tuesday call.

The medical device maker said it intends to retry the lawsuit, as it awaits a decision from the International Trade Commission on a separate investigation into patent infringement claims against Apple.